{
  "pmid": "12819531",
  "uid": "12819531",
  "title": "Distinct cross-resistance profiles of the new protease inhibitors amprenavir, lopinavir, and atazanavir in a panel of clinical samples.",
  "abstract": "A panel of 245 clinical samples with known treatment histories was retrospectively evaluated for cross-resistance to new protease inhibitors (PI). Samples with resistance to previously approved PI displayed high cross-resistance to atazanavir, whereas cross-resistance to amprenavir was considerably lower. A similar cross-resistance profile was observed for lopinavir, if a higher cut-off for resistance (9.5-fold) was applied. The enhanced efficacy of boosted PI is discussed with respect to clinically relevant cut-offs for drug resistance.",
  "authors": [
    {
      "last_name": "Schnell",
      "fore_name": "Tanja",
      "initials": "T",
      "name": "Tanja Schnell",
      "affiliations": [
        "Institute of Clinicaland Molecular Virology, German National Reference Centre for Retroviruses, University of Erlangen-Nuremburg, Erlangen, Germany."
      ]
    },
    {
      "last_name": "Schmidt",
      "fore_name": "Barbara",
      "initials": "B",
      "name": "Barbara Schmidt",
      "affiliations": []
    },
    {
      "last_name": "Moschik",
      "fore_name": "Gitta",
      "initials": "G",
      "name": "Gitta Moschik",
      "affiliations": []
    },
    {
      "last_name": "Thein",
      "fore_name": "Christine",
      "initials": "C",
      "name": "Christine Thein",
      "affiliations": []
    },
    {
      "last_name": "Paatz",
      "fore_name": "Christiane",
      "initials": "C",
      "name": "Christiane Paatz",
      "affiliations": []
    },
    {
      "last_name": "Korn",
      "fore_name": "Klaus",
      "initials": "K",
      "name": "Klaus Korn",
      "affiliations": []
    },
    {
      "last_name": "Walter",
      "fore_name": "Hauke",
      "initials": "H",
      "name": "Hauke Walter",
      "affiliations": []
    }
  ],
  "journal": {
    "title": "AIDS (London, England)",
    "iso_abbreviation": "AIDS",
    "issn": "0269-9370",
    "issn_type": "Print",
    "volume": "17",
    "issue": "8",
    "pub_year": "2003",
    "pub_month": "May",
    "pub_day": "23"
  },
  "start_page": "1258",
  "end_page": "1261",
  "pages": "1258-61",
  "language": "eng",
  "publication_types": [
    "Letter",
    "Research Support, Non-U.S. Gov't"
  ],
  "keywords": [
    "Atazanavir Sulfate",
    "Carbamates",
    "Drug Resistance, Multiple, Viral",
    "Furans",
    "HIV",
    "HIV Protease Inhibitors",
    "Humans",
    "Lopinavir",
    "Oligopeptides",
    "Pyridines",
    "Pyrimidinones",
    "Retrospective Studies",
    "Sulfonamides"
  ],
  "article_ids": {
    "pubmed": "12819531",
    "doi": "10.1097/00002030-200305230-00021"
  },
  "doi": "10.1097/00002030-200305230-00021",
  "dates": {
    "completed": "2003-07-31",
    "revised": "2020-12-08"
  },
  "chemicals": [
    "Carbamates",
    "Furans",
    "HIV Protease Inhibitors",
    "Oligopeptides",
    "Pyridines",
    "Pyrimidinones",
    "Sulfonamides",
    "Lopinavir",
    "Atazanavir Sulfate",
    "amprenavir"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T14:56:12.338850",
    "pmid": "12819531"
  }
}